News
FSNUY
11.26
+3.11%
0.34
Weekly Report: what happened at FSNUY last week (0608-0612)?
Weekly Report · 3h ago
Weekly Report: what happened at FSNUY last week (0601-0605)?
Weekly Report · 06/08 10:28
UBS Sticks to Its Buy Rating for Fresenius SE & Co. KGaA (0OO9)
TipRanks · 06/03 06:36
J.P. Morgan Keeps Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 06/02 05:56
Weekly Report: what happened at FSNUY last week (0525-0529)?
Weekly Report · 06/01 10:34
Weekly Report: what happened at FSNUY last week (0518-0522)?
Weekly Report · 05/25 10:37
Weekly Report: what happened at FSNUY last week (0511-0515)?
Weekly Report · 05/18 10:37
DZ BANK AG Sticks to Its Buy Rating for Fresenius SE & Co. KGaA (0OO9)
TipRanks · 05/12 06:06
Weekly Report: what happened at FSNUY last week (0504-0508)?
Weekly Report · 05/11 10:34
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from Kepler Capital
TipRanks · 05/08 01:49
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from Jefferies
TipRanks · 05/06 12:37
UBS Keeps Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 05/06 12:26
J.P. Morgan Sticks to Their Buy Rating for Fresenius SE & Co. KGaA (0OO9)
TipRanks · 05/06 09:45
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from Barclays
TipRanks · 05/06 07:45
Fresenius SE Non-GAAP EPS of €0.82, revenue of €5.74B; reaffirms FY26 outlook
Seeking Alpha · 05/06 07:28
Weekly Report: what happened at FSNUY last week (0427-0501)?
Weekly Report · 05/04 10:31
Deutsche Bank Remains a Buy on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 04/30 11:42
J.P. Morgan Keeps Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 04/30 11:03
Barclays Remains a Buy on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 04/30 07:09
Weekly Report: what happened at FSNUY last week (0420-0424)?
Weekly Report · 04/27 10:34
More
Webull provides a variety of real-time FSNUY stock news. You can receive the latest news about Fresenius through multiple platforms. This information may help you make smarter investment decisions.
About FSNUY
Fresenius SE & Co KGaA is a Germany-based healthcare company. The Company has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.